LivaNova PLC (NAS:LIVN)
$ 61.38 0.91 (1.5%) Market Cap: 3.32 Bil Enterprise Value: 3.64 Bil PE Ratio: 0 PB Ratio: 2.72 GF Score: 75/100

LivaNova PLC at UBS Global Healthcare Conference (Virtual) Transcript

May 20, 2020 / 02:50PM GMT
Release Date Price: $52.27 (+7.09%)
Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

Great. Good morning. Thanks for joining us for our next session here at the UBS Virtual Global Healthcare Conference. I'm Matt Taylor, UBS' U.S. medical supplies and devices analyst, and I'm really pleased to be joined by management from LivaNova.

So today, we're going to have on the line, Damien McDonald, the CEO. We also got Thad Huston, CFO; and Melissa Farina who leads the IR function at the company. So a lot of opportunity to get insights from assortment of members of the management team. And as everybody knows with these sessions, it will be about a 40-minute Q&A, fireside chat. And if you want to submit questions, you can either e-mail me or push them through the webcast application.

Questions & Answers

Matthew Charles Taylor
UBS Investment Bank, Research Division - Equity Research Analyst of Medical Supplies & Devices

So maybe just to get started, I'll kick it over with a bigger picture question and ask

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot